Search

Showing 91 - 100 of 464 results.

Guidelines

Summary of the current guidelines PMR SMR ESC/EACTS – GUIDELINES FOR THE MANAGEMENT OF VALVULAR HEART DISEASE (2021)16 N/A TMVR is also emer
Options

Treatment options for aortic stenosis: MEDICAL MANAGEMENT Medical treatment options for symptomatic patients with severe AS are limited. Medical treatment may be helpful in ameliorating symptoms in
Guidelines

Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). Interventi
Contact

CONTACT US Contact Us With CONNEXT by Advanced Heart Therapies, Abbott is committed to providing clinicians with best-in-class tailored educational content and sharing best practices and opportuni
Overview

As telemedicine becomes more common, the CardioMEMS HF System is a safe, reliable way to help your patients manage their heart failure. The CardioMEMS HF System offers you real-time notification o
Patients who benefit

Amplatzer™ Muscular VSD Occluders The Amplatzer™ Muscular VSD Occluder is indicated for use in patients with a complex VSD of significant size to warrant closure—large volume left-to-right shunt, p
Overview

Types of VSD There are 4 types of VSDs: Perimembranous Muscular Conal, or subpulmonary Inlet Amplatzer options for Ventricular Septal Defect closure Abbott offers two devices for tran
Clinical Data

U.S. PIVOTAL TRIAL: LOWER RATES OF ADVERSE EVENTS VS SURGERY2 This study was conducted to determine the safety and efficacy of transcatheter ASD closure involving 442 device-closure patients and 91
Key Features

Two Amplatzer™ ASD Closure Devices for Optimizing Patient Care Abbott offers two devices for percutaneous, transcatheter ASD closure.
Patients who benefit

The importance of treating patients with Atrial Septal Defects Patients diagnosed with an ASD, who are indicated for closure with an Amplatzer™ Septal Occluder, exhibit both6: Echocardiographic